When two similar, credible analyses of the same patient database report seemingly contrasting risk estimates for the association with cancer of a widely-prescribed therapy, it is difficult for clinicians, never mind for patients, to make decisions about treatment options. Nevertheless, clinicians can—and must—interpret the available evidence for their patients, helping them to weigh the potential benefits and harms of their prescription.
- William G. Dixon
- Daniel H. Solomon